Veterinary medicines: highlights of 2015
14 medicines recommended for approval; half of them contain a new active substance
The European Medicines Agency (EMA) has released an overview of its 2015 key recommendations in relation to the marketing authorisations of new veterinary medicines and the safety monitoring of authorised veterinary medicines.
New vaccines will help to prevent of diseases in food-producing species such as dairy cattle, chicken and pigs. In addition, medicines with the potential to reduce the need for antimicrobial treatments in food-producing animals will contribute to safeguard food security and combat the risk of antimicrobial resistance.
In 2015, EMA recommended a total of 14 veterinary medicines for marketing authorisation to the European Commission. Of these, seven medicines contained a new active substance.
Monitoring in real life – optimising safe and effective use
Once a veterinary medicine has been put on the market, EMA and the EU Member States continuously monitor the benefits and risks associated with this medicine in real life for human and animal health and for the environment. This is to ensure that the medicine is used in the best possible way by practitioners in the EU.
In 2015, EMA gave new safety advice to manage risks observed with a number of medicines on the market in the EU. The product information of these medicines was updated to ensure the optimal use of the medicines by veterinarians.
A selection of these recommendations can be found in the document published today.
How useful is this page?
Average rating:Based on 7 ratings
Add your rating:
- See all ratings
1 ratings1 ratings1 ratings0 ratings4 ratings